News | September 11, 2007

Anastomosis System Gets CE Approval for Coronary Artery Bypass Surgery

September 12, 2007 - Cardica Inc. received the European CE Mark (Conformite Europeenne) for the C-Port Flex A Anastomosis System, a device that facilitates the automated anastomosis during less invasive coronary artery bypass graft (CABG) procedures.

The C-Port Flex A Anastomosis System is a variation of Cardica's C-Port xA Distal Anastomosis System product line. The C-Port Flex A system features several modifications to Cardica's C-Port xA system, which is designed to enable automated, reliable and reproducible connections of blood vessels during CABG surgery. The C-Port Flex A system has a flexible, rather than rigid, shaft; reportedly creates compliant anastomoses in vessels as small as one millimeter in internal diameter and, can be used in either on- or off-pump CABG procedures. The flexible shaft assists surgeons in positioning the device to create a secure connection even in difficult to reach areas of the heart.
Recently, two independent groups of leading cardiothoracic surgeons in the U.S. performed minimally invasive, closed-chest bypass procedures using Cardica's C-Port Flex A Anastomosis System and Intuitive Surgical's da Vinci Surgical System.
The Flex A received 510(k) clearance from the U.S. Food and Drug Administration in March 2007.

For more information: www.cardica.com

Related Content

National Institute of Health Campus

Feature | June 06, 2013
The National Institutes of Health (NIH), the nation’s medical research agency and the leading supporter of biomedical...
News | April 16, 2012
April 16, 2012 — Philips Healthcare announced it is collaborating with Brainlab AG to create a comprehensive intra-...
Technology | February 24, 2011
February 24, 2011 – A percutaneous microwave tissue ablation (pMTA) system will be unveiled at the European Congress of...
News | August 12, 2008
August 13, 2008 - The University of Pennsylvania's School of Medicine will host a one-day medical education conferenc
News | November 03, 2007
November 4, 2007 - The prevalence of asymptomatic peripheral artery disease (PAD) is steadily increasing among Americ
News | September 09, 2007
September 10, 2007 - Signalife launched the sales of its new, FDA-approved, ambulatory 12-lead ECG cardiovascular mon
Overlay Init